venture
Nov 07, 2017
Teva sells generics; Valeant trades; Roche’s Genentech; J&J’s next potential frontier
Teva looks to sell generics in China through joint venture with Guangzhou Pharma As the world’s largest generics maker, Teva still doesn’t have much of a presence in China, even though it is a country relies heavily on generics. The Israeli company is looking to remedy that as Teva has said it “has no agreement with...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
